UHD-32205-73103 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-24
Dose 1 — Pfizer-BioNTech
2021-01-16
Dose 2 — Pfizer-BioNTech
2021-01-25
Registered in v-safe
2021-01-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-30
Survey response — day 14, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: New dx of pregnancy, LMP 12/28/2020, was very early in pregnancy with second vaccine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-20
Survey response — day 35, dose 2
MedDRA: Abortion spontaneous, Gastroenteritis, Norovirus infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Miscarriage, norovirus gastroenteritis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-20
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Call 1 — Left Voicemail
2021-03-01
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-03-01
Call successful
Participant prefers to complete VAERS report online
2021-04-17
Survey response — 3 months, dose 2
MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-17
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-19
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-07-22
Survey response — 6 months, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnancy, now 22 weeks

MedDRA releases: 2024-11 · check-in free text available
2021-09-17
Dose 3 — Pfizer-BioNTech
2022-01-18
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-17
Survey response — 12 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school

Free text: COVID may 2022

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-24	Pfizer-BioNTech
2	2021-01-16	Pfizer-BioNTech
3	2021-09-17	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-02-20	Successful 2021-03-01	Participant prefers to complete VAERS report online
2021-04-17	Successful 2021-04-19	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 3 — day 14, dose 2

2021-01-30

Symptoms: New dx of pregnancy, LMP 12/28/2020, was very early in pregnancy with second vaccine

Release 4 — day 35, dose 2

2021-02-20

Symptoms: Miscarriage, norovirus gastroenteritis

Release 7 — 3 months, dose 2

2021-04-17

Symptoms: Pregnancy

Release 9 — 6 months, dose 2

2021-07-22

Symptoms: Pregnancy, now 22 weeks

Release 12 — 12 months, dose 3

2022-09-17

Symptoms: COVID may 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Gastroenteritis	✓	✓	✓
SD	Norovirus infection	✓	✓	✓
SD	Pregnancy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release